PATENT CLAIM ANALYSIS

Application Number: 16040160
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "950000"]

Abstract:
A formulation, especially one that is topically administered, comprising a combination of rapamcycin and metformin in a molar ratio of about 20:1, 10:1, 5:1, 4:1, 3:1, or 1:1. The topical formulation may be a gel, an ointment, a cream or a lotion. The topical formulation may be used to treat a condition or disease of the skin or eye, wherein the condition or disease is associated with mTORC1 activation.

Claim (Index 10):
The method of  claim 7 , wherein the molar ratio of rapamycin to metformin is about 5.1 to about 4:1.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.64
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15164647', '15595911', '15817057', '13866936', '14746516']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6914429548567986
- 35 USC 102 Novelty (BERT): 0.5163845632676607
- Combined Prediction Score: 0.673937115697885
- Mean Citation Score: 203.53568
- Max Citation Score: 208.07088
- Similarity Product: 120.31826187995908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test